66 related articles for article (PubMed ID: 15381252)
1. Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytes.
Jimenez JL; Iñiguez MA; Muñoz-Fernández MA; Fresno M
Cell Signal; 2004 Dec; 16(12):1363-73. PubMed ID: 15381252
[TBL] [Abstract][Full Text] [Related]
2. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway.
Granja AG; Nogal ML; Hurtado C; Vila V; Carrascosa AL; Salas ML; Fresno M; Revilla Y
J Biol Chem; 2004 Dec; 279(51):53736-46. PubMed ID: 15471864
[TBL] [Abstract][Full Text] [Related]
3. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes.
Iñiguez MA; Martinez-Martinez S; Punzón C; Redondo JM; Fresno M
J Biol Chem; 2000 Aug; 275(31):23627-35. PubMed ID: 10816557
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M
J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691
[TBL] [Abstract][Full Text] [Related]
5. Cot kinase induces cyclooxygenase-2 expression in T cells through activation of the nuclear factor of activated T cells.
de Gregorio R; Iñiguez MA; Fresno M; Alemany S
J Biol Chem; 2001 Jul; 276(29):27003-9. PubMed ID: 11356833
[TBL] [Abstract][Full Text] [Related]
6. Treatment of human T cells with bisperoxovanadium phosphotyrosyl phosphatase inhibitors leads to activation of cyclooxygenase-2 gene.
Barat C; Tremblay MJ
J Biol Chem; 2003 Feb; 278(9):6992-7000. PubMed ID: 12493747
[TBL] [Abstract][Full Text] [Related]
7. Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes.
Bodor J; Bodorova J; Bare C; Hodge DL; Young HA; Gress RE
Eur J Immunol; 2002 Jan; 32(1):203-12. PubMed ID: 11754361
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes.
Ekholm D; Mulloy JC; Gao G; Degerman E; Franchini G; Manganiello VC
Biochem Pharmacol; 1999 Sep; 58(6):935-50. PubMed ID: 10509746
[TBL] [Abstract][Full Text] [Related]
9. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
Bartsch O; Bartlick B; Ivell R
J Clin Endocrinol Metab; 2004 Jan; 89(1):324-34. PubMed ID: 14715868
[TBL] [Abstract][Full Text] [Related]
11. Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis.
Tiwari S; Felekkis K; Moon EY; Flies A; Sherr DH; Lerner A
Blood; 2004 Apr; 103(7):2661-7. PubMed ID: 14615375
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2.
Duque J; Fresno M; Iñiguez MA
J Biol Chem; 2005 Mar; 280(10):8686-93. PubMed ID: 15632146
[TBL] [Abstract][Full Text] [Related]
13. Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts.
Cho ES; Yu JH; Kim MS; Yim M
Yonsei Med J; 2005 Feb; 46(1):149-54. PubMed ID: 15744818
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells.
Michaelis UR; Falck JR; Schmidt R; Busse R; Fleming I
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):321-6. PubMed ID: 15569819
[TBL] [Abstract][Full Text] [Related]
15. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors.
Liu S; Veilleux A; Zhang L; Young A; Kwok E; Laliberté F; Chung C; Tota MR; Dubé D; Friesen RW; Huang Z
J Pharmacol Exp Ther; 2005 Aug; 314(2):846-54. PubMed ID: 15901792
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a role of phosphodiesterase 4 in lipopolysaccharide-stimulated prostaglandin E2 production and matrix metalloproteinase-9 activity in human amniochorionic membranes.
Oger S; Méhats C; Dallot E; Cabrol D; Leroy MJ
J Immunol; 2005 Jun; 174(12):8082-9. PubMed ID: 15944316
[TBL] [Abstract][Full Text] [Related]
18. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
19. Induction of cyclooxygenase-2 expression by allergens in lymphocytes from allergic patients.
Chacón P; Vega A; Monteseirín J; El Bekay R; Alba G; Pérez-Formoso JL; Msartínez A; Asturias JA; Pérez-Cano R; Sobrino F; Conde J
Eur J Immunol; 2005 Aug; 35(8):2313-24. PubMed ID: 15997464
[TBL] [Abstract][Full Text] [Related]
20. KF19514, a phosphodiesterase 4 and 1 inhibitor, inhibits TNF-alpha-induced GM-CSF production by a human bronchial epithelial cell line via inhibition of PDE4.
Sasaki K; Manabe H
Inflamm Res; 2004 Jan; 53(1):31-7. PubMed ID: 15021978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
